John F. Valliant

6.2k citations

153 papers · 4.5k indexed · 1 hit paper · h-index 33

Radiology, Nuclear Medicine and Imaging top 0.2%
Organic Chemistry top 1%
Oncology top 2%
Materials Chemistry top 5%
Molecular Biology top 10%

Co-authors: Jon Zubieta Paul Schaffer Andrea Armstrong John W. Babich Karin A. Stephenson Kevin Maresca Oyebola O. Sogbein Pierre Morel
Topics: Radiopharmaceutical Chemistry and Applications (117 papers)Medical Imaging Techniques and Applications (39 papers)Boron Compounds in Chemistry (35 papers)
Cited by: Radiology, Nuclear Medicine and Imaging Organic Chemistry Inorganic Chemistry
Journals: Chemical Reviews Journal of the American Chemical Society Angewandte Chemie International Edition
Partner nations: Canada United States Egypt

In The Last Decade

John F. Valliant

149 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The medicinal chemistry of carboranes

2002 593 citations John F. Valliant, Paul Schaffer et al. profile →

Peers

Countries citing papers authored by John F. Valliant

Since Specialization

Citations

This map shows the geographic impact of John F. Valliant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John F. Valliant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John F. Valliant more than expected).

Fields of papers citing papers by John F. Valliant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John F. Valliant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John F. Valliant. The network helps show where John F. Valliant may publish in the future.

Co-authorship network of co-authors of John F. Valliant

This figure shows the co-authorship network connecting the top 25 collaborators of John F. Valliant. A scholar is included among the top collaborators of John F. Valliant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John F. Valliant. John F. Valliant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Photoacoustic imaging of a cyanine dye targeting bacterial infection 2024 ·Scientific Reports ·(unknown),(unknown),(unknown),(unknown),Mohamed E. El‐Zaria,Afaf R. Genady,Jacek M. Kwiecień,John F. Valliant,Saman Sadeghi	2
2	Pretargeted PET of Osteodestructive Lesions in Dogs 2022 ·Molecular Pharmaceutics ·Charles A. Maitz,(unknown),Brendon E. Cook,Afaf R. Genady,(unknown),(unknown),Georgios Makris,John F. Valliant,Saman Sadeghi,Jason S. Lewis,Heather M. Hennkens,Jeffrey N. Bryan,Brian M. Zeglis	9
3	Synthesis and Preclinical Evaluation of [¹⁸F]SiFA-PSMA Inhibitors in a Prostate Cancer Model 2021 ·Journal of Medicinal Chemistry ·Justin J. Bailey,Melinda Wuest,Michael Wagner,Atul Bhardwaj,Carmen Wängler,Björn Wängler,John F. Valliant,Ralf Schirrmacher,Frank Wuest	10
4	A Versatile Platform for the Development of Radiolabeled Antibody-Recruiting Small Molecules 2021 ·Molecular Pharmaceutics ·(unknown),Afaf R. Genady,Nancy Janzen,Varun C. Anipindi,(unknown),Anthony F. Rullo,Saman Sadeghi,John F. Valliant	5
5	Tetrazine-Derived Near-Infrared Dye as a Facile Reagent for Developing Targeted Photoacoustic Imaging Agents 2020 ·Molecular Pharmaceutics ·(unknown),(unknown),Nancy Janzen,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Christine Démoré,F. Stuart Foster,John F. Valliant	4
6	^99mTc-Functionalized Single-Walled Carbon Nanotubes for Bone Targeting 2020 ·ACS Applied Nano Materials ·Afaf R. Genady,Darryl Fong,(unknown),Mohamed E. El‐Zaria,(unknown),Nancy Janzen,(unknown),(unknown),Mojgan Rezvani,Saman Sadeghi,Alex Adronov,John F. Valliant	12
7	[ ¹⁸ F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trial 2020 ·BMJ Open ·Rachel Glicksman,Ur Metser,John F. Valliant,Peter Chung,Neil Fleshner,Robert G. Bristow,David Green,Antonio Finelli,Robert J. Hamilton,(unknown),Douglas Hussey,Charles Catton,Mary Gospodarowicz,Padraig Warde,Andrew Bayley,Stephen Breen,(unknown),David A. Jaffray,Alejandro Berlín	6
8	Development of prostate specific membrane antigen targeted ultrasound microbubbles using bioorthogonal chemistry 2017 ·PLoS ONE ·Aimen Zlitni,Melissa Yin,Nancy Janzen,Samit Chatterjee,Ala Lisok,Kathleen L. Gabrielson,Sridhar Nimmagadda,Martin G. Pomper,F. Stuart Foster,John F. Valliant	11
9	Preparation of tetrazine-containing [2 + 1] complexes of ^99mTc and in vivo targeting using bioorthogonal inverse electron demand Diels–Alder chemistry 2017 ·Dalton Transactions ·(unknown),Nancy Janzen,(unknown),Robert G. Ungard,(unknown),Gurmit Singh,John F. Valliant	13
10	Technetium(I) Complexes of Bathophenanthrolinedisulfonic Acid 2017 ·Inorganic Chemistry ·(unknown),Nancy Janzen,(unknown),John F. Valliant	11
11	Targeting Prostate-Specific Membrane Antigen (PSMA) with F-18-Labeled Compounds: the Influence of Prosthetic Groups on Tumor Uptake and Clearance Profile 2017 ·Molecular Imaging and Biology ·Vincent Bouvet,Melinda Wuest,Justin J. Bailey,(unknown),Nancy Janzen,John F. Valliant,Frank Wuest	23
12	A 99mTc-Labelled Tetrazine for Bioorthogonal Chemistry. Synthesis and Biodistribution Studies with Small Molecule trans-Cyclooctene Derivatives 2016 ·PLoS ONE ·Alyssa Vito,(unknown),(unknown),(unknown),(unknown),Nancy Janzen,Afaf R. Genady,(unknown),(unknown),(unknown),(unknown),(unknown),Paul J. Berti,John F. Valliant	19
13	Preparation of an ¹⁸F‐Labeled Hydrocyanine Dye as a Multimodal Probe for Reactive Oxygen Species 2016 ·Chemistry - A European Journal ·(unknown),(unknown),Alyssa Vito,Nancy Janzen,(unknown),(unknown),Max Nanao,Jon Zubieta,Alfredo Capretta,John F. Valliant	44
14	Design and synthesis of [125I]Pyricoxib: A novel 125I-labeled cyclooxygenase-2 (COX-2) inhibitors 2016 ·Bioorganic & Medicinal Chemistry Letters ·Ole Tietz,(unknown),Atul Bhardwaj,John F. Valliant,Frank Wuest	7
15	High Yielding Synthesis of Carboranes Under Mild Reaction Conditions Using a Homogeneous Silver(I) Catalyst: Direct Evidence of a Bimetallic Intermediate 2014 ·Angewandte Chemie International Edition ·Mohamed E. El‐Zaria,Kunal Keskar,Afaf R. Genady,(unknown),James McNulty,John F. Valliant	34
16	Synthesis, Characterisation, and Biodistribution of Radioiodinated C‐Hydroxy‐Carboranes 2012 ·Chemistry - A European Journal ·Mohamed E. El‐Zaria,Nancy Janzen,(unknown),John F. Valliant	16
17	Emulsion Reactors: A New Technique for the Preparation of Molecular Imaging Probes 2012 ·Chemistry - A European Journal ·Ryan Simms,Dong Hyun Kim,(unknown),Chitra Sundararajan,(unknown),Karin A. Stephenson,John F. Valliant	5
18	The bioinorganic and medicinal chemistry of carboranes: from new drug discovery to molecular imaging and therapy 2007 ·Dalton Transactions ·Andrea Armstrong,John F. Valliant	295
19	Design and synthesis of site directed maleimide bifunctional chelators for technetium and rhenium 2005 ·Dalton Transactions ·Sangeeta Ray Banerjee,Paul Schaffer,John W. Babich,John F. Valliant,Jon Zubieta	36
20	Bridging the Gap between in Vitro and in Vivo Imaging: Isostructural Re and ^99m Tc Complexes for Correlating Fluorescence and Radioimaging Studies 2004 ·Journal of the American Chemical Society ·Karin A. Stephenson,Sangeeta Ray Banerjee,Travis R. Besanger,Oyebola O. Sogbein,M.K. Levadala,Nicole McFarlane,Jennifer A. Lemon,Douglas R. Boreham,Kevin Maresca,John D. Brennan,John W. Babich,Jon Zubieta,John F. Valliant	167

About John F. Valliant

John F. Valliant is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pharmaceutical Science, having authored 153 papers that have together received 4.5k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (117 papers), Medical Imaging Techniques and Applications (39 papers) and Boron Compounds in Chemistry (35 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (3.2k citations), Organic Chemistry (1.3k citations) and Inorganic Chemistry (628 citations). John F. Valliant has collaborated with scholars based in Canada, United States and Egypt. Frequent co-authors include Jon Zubieta, Paul Schaffer, Andrea Armstrong, John W. Babich, Karin A. Stephenson, Kevin Maresca, Oyebola O. Sogbein, Pierre Morel, Mark Bartholomä and Katharina J. Guenther. Their work appears in journals such as Chemical Reviews, Journal of the American Chemical Society and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact